FDA.reportPublic FDA data

ALCAFTADINE

Substance profile for UNII 7Z8O94ECSX, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for ALCAFTADINE
Structure render from PubChem CID 19371515

Substance Identity#

UNII
7Z8O94ECSX
Preferred term
ALCAFTADINE
Registry number
147084-10-4
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C19H21N3O
Chemical structure for ALCAFTADINE
Structure render from PubChem CID 19371515

Chemical And Database Identifiers#

InChIKey
MWTBKTRZPHJQLH-UHFFFAOYSA-N
SMILES
CN1CCC(CC1)=C2C3=NC=C(C=O)N3CCC4=C2C=CC=C4
RxCUI
1000082
PubChem
19371515
NCIt
C72686
INN ID
8707

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound19371515pubchem.ncbi.nlm.nih.gov/compound/19371515
PubChem InChIKey SearchMWTBKTRZPHJQLH-UHFFFAOYSA-Npubchem.ncbi.nlm.nih.gov/#query=MWTBKTRZPHJQLH-UHFFFAOYSA-N
RxNorm1000082mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1000082
NCI ThesaurusC72686ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C72686
FDA Substance Registration System7Z8O94ECSXprecision.fda.gov/uniisearch/srs/unii/7Z8O94ECSX

DailyMed Socrata Ingredients#

Type, DailyMed label, SPL version table
TypeDailyMed labelSPL version
ACTIVE INGREDIENTThese highlights do not include all the information needed to use LASTACAFT ® safely and effectively. See full prescribing information for LASTACAFT ® . LASTACAFT ® (alcaftadine ophthalmic solution) 0.25% Initial U.S. Approval: 20101
ACTIVE MOIETYThese highlights do not include all the information needed to use LASTACAFT ® safely and effectively. See full prescribing information for LASTACAFT ® . LASTACAFT ® (alcaftadine ophthalmic solution) 0.25% Initial U.S. Approval: 20101
ACTIVE MOIETYThese highlights do not include all the information needed to use LASTACAFT™ safely and effectively. See full prescribing information for LASTACAFT™. LASTACAFT™ (alcaftadine ophthalmic solution) 0.25% Initial U.S. Approval: 20101
ACTIVE INGREDIENTThese highlights do not include all the information needed to use LASTACAFT™ safely and effectively. See full prescribing information for LASTACAFT™. LASTACAFT™ (alcaftadine ophthalmic solution) 0.25% Initial U.S. Approval: 20101
ACTIVE MOIETYLASTACAFT (ALCAFTADINE) SOLUTION/ DROPS [ALLERGAN, INC.]8
ACTIVE INGREDIENTLASTACAFT (ALCAFTADINE) SOLUTION/ DROPS [ALLERGAN, INC.]8